Oral DNA Vaccination in Combination With Checkpoint Inhibitor In Recurrent Glioblastoma
Time: 5:15 pm
day: Day One
Details:
- Cytotoxic T-cell approach targeting VEGFR-2 on tumor vasculature and tumor cells
- Combination with checkpoint inhibitors
- Intratumoral immune-biomarkers pre- and post treatment
